Who owns the BACTIMUNE trademark?

The BACTIMUNE trademark is owned by ProbioFerm, LLC.

What class is the BACTIMUNE trademark registered in?

The BACTIMUNE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for BACTIMUNE?

The USPTO serial number for BACTIMUNE is 98342292.

What is the registration number for BACTIMUNE?

BACTIMUNE is registered under USPTO registration number 8223924.

Sealvo

Home Search: BACTIMUNEBACTIMUNE #98342292

Back

Updated Sep 27, 2026·12 searches this week

View on USPTO TSDR Find similar marks

BAC

USPTO Trademark Record

REGISTERED

BACTIMUNE

SN 98342292·Reg 8223924·Filed Jan 04, 2024

Owner ProbioFerm, LLC

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

BACTIMUNE (Serial No. 98342292), Registration No. 8223924, is a registered US trademark filed on Jan 04, 2024 by ProbioFerm, LLC. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: April 21, 2032

Conflict Analysis

Full conflict analysis for BACTIMUNE (SN 98342292) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

BACTIMUNE (Reg. #8223924) is a registered US trademark that has been protecting its owner, ProbioFerm, LLC, since 2024. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jan 04, 2024

SERIAL

98342292

REG#

8223924

REGISTERED

Apr 21, 2026

Filing Information

StatusREGISTERED

Filing DateJan 04, 2024

Serial Number98342292

Registration No.8223924

Registration DateApr 21, 2026

Status DateApr 21, 2026

Published for OppositionJan 28, 2025

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Jul 22, 2025

First use in commerce: Jul 22, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

22 events

REGISTERED-PRINCIPAL REGISTER

Apr 21, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 21, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Apr 02, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Apr 02, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Mar 26, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Mar 26, 2026

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Sep 24, 2025

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Sep 24, 2025

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Mar 25, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jan 28, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 28, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 22, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 28, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 22, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 22, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 22, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO EXAMINER

Aug 01, 2024

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Aug 01, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Aug 01, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 01, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 22, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jan 04, 2024

NEW APPLICATION ENTERED

Other Marks by ProbioFerm, LLC

Additional USPTO filings from the same owner.

DUR

DURABAC

77823438

PROBIOFERM, LLC

REGISTERED

PRO

PROBIOFERM

77826628

PROBIOFERM, LLC

REGISTERED

Other Marks by Jordan Meggison-Decker

Additional USPTO filings handled by the same attorney of record.

GRO

GROWERS EDGE FINANCIAL

88132945

REGISTERED

CLA

CLASSIC GREEN

88536110

REGISTERED

CLA

CLASSIC GREEN

88536230

REGISTERED

CON

CONTINUWING

88935100

REGISTERED

BACTIMUNE

Run a conflict check

Other Marks by ProbioFerm, LLC

Other Marks by Jordan Meggison-Decker

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company